Previous Page  8 / 31 Next Page
Information
Show Menu
Previous Page 8 / 31 Next Page
Page Background

Page 92

Notes:

conferenceseries

.com

Volume 12

Journal of Molecular and Genetic Medicine

ISSN: 1747-0862

May 21-23, 2018 Barcelona, Spain

&

Integrative Biology

6

th

International Conference on

Genomics and Molecular Biology

10

th

International Conference on

Genomics 2018 and Integrative Biology 2018

May 21-23, 2018

JOINT EVENT

Onco-Plus: an integrated database and computational protocol for discovery of lead molecules

targeting unique DNA

Akhilesh Mishra, Pradeep Pant and B Jayaram

IIT Delhi, India

T

he specific binding of transcription factors (TFs) to specific DNA sequences make the DNA motifs promising drug targets

for the coordinated regulation of gene expression. Here, we present Onco-Plus, an integrated database of regulatory motifs

of cancer genes clubbed with Unique Sequence Predictor (USP)

(http://www.scfbio-iitd.res.in/software/onco/NavSite/index.

htm) and a software suite for targeting DNA for drug discovery. USP identifies unique sequences (i.e. these sequences occur

only once in the entire genome and if targeted would presumably show no off-target binding /side effects) for each of the

identified regulatory DNA motifs at the specified position in the genome by extending a given DNA motif, in 5’→3’or 3’→5’ or

in both directions. For each identified motif, three possible unique sequences could be generated. Taking off from the identified

unique sequences as drug targets, a rapid virtual screening against a million-compound library could be performed (http://

www.scfbio-iitd.res.in/PSDDF/tool4.php

) to generate a list of hit molecules (potential candidate drugs) with their predicted

binding free energies. This methodology is demonstrated on E2F transcription factor binding site for the WNT10B gene,

implicated in breast and endometrial cancers and a few small molecules are proposed as potential drug candidates. Being fast

and cost effective, this protocol could be of considerable value in generating new potential drug candidates to inhibit desired

sequences for further experimental studies.

Biography

Akhilesh Mishra has done his Master’s in Bioinformatics from Jamia Millia Islamia, New Delhi, India. He is pursuing his PhD from Indian Institute of Technology, New

Delhi. He is the Recipient of CSIR-UGC-SRF and BINC award from the Department of Biotechnology, India. He has published many research articles in reputed

peer reviewed journals.

Akhilesh.mishra88@gmail.com

Akhilesh Mishra et al., J Mol Genet Med 2018, Volume 12

DOI: 10.4172/1747-0862-C2-028